Nov 4, 2024, 15:17
Erman Akkus: Adjuvant endocrine and chemotherapy in HR+/HER2- breast cancer
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X:
“Adjuvant endocrine and chemotherapy in HR(+) HER2(-) breast cancer.
Menopause status, N status and RS score table.”
More posts featuring Erman Akkus.
Erman Akkus is a medical oncology fellow at the Ankara University, Faculty of Medicine. Previously, he was an Internal Medicine Resident at the Ankara University, Faculty of Medicine. He was also a Visiting Researcher at the University of Oslo. He completed his education from the Medical University of Vienna.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 08:39
Nov 12, 2024, 23:10
Nov 12, 2024, 23:07
Nov 12, 2024, 22:58
Nov 12, 2024, 22:56